Matches in Wikidata for { <http://www.wikidata.org/entity/Q65381709> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q65381709 description "clinical trial" @default.
- Q65381709 description "ensayu clínicu" @default.
- Q65381709 description "klinisch onderzoek" @default.
- Q65381709 description "клінічне випробування" @default.
- Q65381709 name "Phase III Trial in Acute Promyelocytic Leukemia Patients" @default.
- Q65381709 name "Phase III Trial in Acute Promyelocytic Leukemia Patients" @default.
- Q65381709 type Item @default.
- Q65381709 label "Phase III Trial in Acute Promyelocytic Leukemia Patients" @default.
- Q65381709 label "Phase III Trial in Acute Promyelocytic Leukemia Patients" @default.
- Q65381709 prefLabel "Phase III Trial in Acute Promyelocytic Leukemia Patients" @default.
- Q65381709 prefLabel "Phase III Trial in Acute Promyelocytic Leukemia Patients" @default.
- Q65381709 P1050 Q65381709-C2ECB119-26D3-466B-8884-3CBE62024B39 @default.
- Q65381709 P1132 Q65381709-70E9FF6C-3365-4E6C-A23C-BA57863F1E0F @default.
- Q65381709 P1476 Q65381709-E1D6B061-CBB4-4FA8-BDE3-52E961388984 @default.
- Q65381709 P17 Q65381709-1D68F201-39A9-47E8-87B0-F0FCCCA9F8FA @default.
- Q65381709 P17 Q65381709-C4D82BCE-6BC5-49BE-A95E-6A71497FC19B @default.
- Q65381709 P17 Q65381709-D42632F0-4691-459D-BBE9-4F3AA18859FF @default.
- Q65381709 P1813 Q65381709-BC4E636A-DDEF-4893-B748-B3859E22473E @default.
- Q65381709 P2899 Q65381709-D1EF537C-6817-42AA-A003-C1CC5565C39D @default.
- Q65381709 P3098 Q65381709-3581A8EB-8A9E-4377-B4D2-9BEE974BC79A @default.
- Q65381709 P31 Q65381709-D82F62C6-8E02-400B-961C-2C6839F6AC61 @default.
- Q65381709 P4135 Q65381709-B087684E-FA67-47AD-BDD5-9E6962580DA3 @default.
- Q65381709 P4844 Q65381709-181DF7CB-EBF5-4CB4-82D8-63358631D28A @default.
- Q65381709 P4844 Q65381709-215F8834-6E3B-444E-AD1A-E6C3C758BD45 @default.
- Q65381709 P4844 Q65381709-943BD3A3-EB73-46F6-9AC9-767D1797D78A @default.
- Q65381709 P580 Q65381709-F785A0C1-A83A-41E9-9563-B37100A33769 @default.
- Q65381709 P582 Q65381709-D50DF7DD-A628-4F16-8112-2A2DE0207922 @default.
- Q65381709 P6099 Q65381709-C5ED9EC9-3B6B-4077-BB7B-1D4FBC096CF1 @default.
- Q65381709 P6153 Q65381709-03E6C6E0-BDED-4D99-892B-28F86C8781B5 @default.
- Q65381709 P6153 Q65381709-3DC7CAA3-7DEE-48E9-BB4F-FC9CEAF57B18 @default.
- Q65381709 P6153 Q65381709-A2E4F8E7-B811-4061-80DE-76371570B297 @default.
- Q65381709 P6153 Q65381709-BC0171D9-1692-455A-8BDE-BA6D7C809F25 @default.
- Q65381709 P8363 Q65381709-1AA1C09A-2A0D-4BAB-AC3D-7E6C1610532C @default.
- Q65381709 P859 Q65381709-53830CE2-2557-4B2C-8D50-005D68F0E514 @default.
- Q65381709 P1050 Q29496 @default.
- Q65381709 P1132 "+276" @default.
- Q65381709 P1476 "A Randomised Phase III Study to Compare Arsenic Trioxide (ATO) Combined to ATRA Versus Standard ATRA and Anthracycline-Based Chemotherapy (AIDA Regimen) for Newly Diagnosed, Non High-Risk Acute Promyelocytic Leukemia" @default.
- Q65381709 P17 Q183 @default.
- Q65381709 P17 Q38 @default.
- Q65381709 P17 Q40 @default.
- Q65381709 P1813 "APL0406" @default.
- Q65381709 P2899 "+18" @default.
- Q65381709 P3098 "NCT00482833" @default.
- Q65381709 P31 Q30612 @default.
- Q65381709 P4135 "+70" @default.
- Q65381709 P4844 Q1063862 @default.
- Q65381709 P4844 Q29417 @default.
- Q65381709 P4844 Q418529 @default.
- Q65381709 P580 "2007-08-01T00:00:00Z" @default.
- Q65381709 P582 "2012-09-01T00:00:00Z" @default.
- Q65381709 P6099 Q42824827 @default.
- Q65381709 P6153 Q19358919 @default.
- Q65381709 P6153 Q22679063 @default.
- Q65381709 P6153 Q3966437 @default.
- Q65381709 P6153 Q911561 @default.
- Q65381709 P8363 Q78089383 @default.
- Q65381709 P859 Q3764428 @default.